Genomic Health (NASDAQ: GHDX) reported Q1 EPS of ($0.11), $0.11 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $92.6 million versus the consensus estimate of $88.96 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.